|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash flows | |||||
| Depreciation of property, plant and equipment and right-of-use assets and amortization of intangible assets | |||||
| Impairment of property, plant and equipment and right-of-use assets and intangible assets | |||||
| Impairment loss/(gain)on trade receivables | |||||
| Write-down of inventories | |||||
| Share-based compensation | |||||
| Movements in provisions | |||||
| Finance income | |||||
| Finance expenses | |||||
| Income tax expense | |||||
| (Gain)/Loss on disposal of property, plant and equipment and intangible assets | |||||
| Impairment related to discontinued construction of production facilities | |||||
| Impairment related to closure of production facility | |||||
| Other | |||||
| Interest received | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Changes in working capital: | |||||
| (Increase)/decrease in inventories | |||||
| Decrease/(increase) in trade receivables, other current receivables, prepaid expenses | |||||
| Increase/(decrease) in trade payables, other current liabilities, accrued expenses | |||||
| Net cash flows used in operating activities | |||||
| Investing activities | |||||
| Purchase of intangible assets | |||||
| Purchase of property, plant and equipment | |||||
| Investments in financial assets | |||||
| Proceeds from sales of property, plant and equipment | |||||
| Proceeds from sale of assets held for sale | |||||
| Other | |||||
| Net cash flows used in investing activities | |||||
| Financing activities | |||||
| Proceeds from Convertible Notes/bonds | |||||
| Proceeds from liabilities to credit institutions | |||||
| Repayment of liabilities to credit institutions | |||||
| Repurchase of U.S. Notes | |||||
| Repayment of lease liabilities | |||||
| Payment of loan transaction costs | |||||
| Proceeds from exercise of stock options | |||||
| Cash flows from/(used in) financing activities | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at January 1 | |||||
| Exchange rate differences in cash and cash equivalents | |||||
| Cash and cash equivalents at December 31 | |||||
Loading...